Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flupentixol and melitracen for aerophagia
ChiCTR-IPR-15006869Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of flupentixol + melitracen and itopride in Aerophagia (3 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Aerophagia symptom score and Safety evaluation. Started Dec 2011; status: completed.
02
Drugs
flupentixol + melitracenitopride
03
Conditions
Aerophagia
Beyond the preview
Go deeper on ChiCTR-IPR-15006869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006869.